Preclinical evaluation of 64Cu-labeled cetuximab in immuno-PET for detecting sentinel lymph node metastasis in epidermal growth factor receptor-positive breast cancer
Takeshi Usui(The University of Osaka), Kenzo Shimazu(The University of Osaka)
Cited by 3